Pharmacists can also inquire with their malpractice insurance company about the need for additional coverage related to improving the role in patient care. With increased power comes additional responsibility for pharmacists practicing under expanded collaborative practice agreements. For example, Ohio pharmacists practicing under collaborative arrangements will soon have the authority to enter into agreements with multiple physicians to manage the drug treatment of multiple patients. Under these expanded agreements, Ohio pharmacists can also order lab tests and then modify drug treatment based on the results. Under extended agreements, pharmacists can enter into agreements with multiple physicians to manage the medication treatment of multiple patients. Despite the increased potential for professional misconduct and liability, Ciaccia touted the expansion of Ohio`s Collaborative Practice Agreements Act as a victory for prescribing physicians, pharmacists, and patients. “[The Ohio Pharmacists Association] is currently developing several educational programs to help pharmacists better understand the possibilities of the new laws and focus on some of the liability issues,” he said. “Pharmacists are by nature very process-oriented. (therefore), it is important to provide them with the information and tools they need to securely and seamlessly integrate new services and programs into their practice,” he noted. Antonio Ciaccia, director of government and public affairs for the Ohio Pharmacists Association, told the Pharmacy Times that the state`s new laws agreeing on collaborative practices will have a huge impact on all pharmaceutical practices, including preparedness, long-term care, hospitals, outpatients, community and counseling. “It is well known that the pharmacist`s involvement in the healthcare team is an important factor in improving outcomes,” he said.
“When it comes to possibilities for pharmacists, according to this new law, the sky is the limit.” The contract templates can be viewed and downloaded from the following links: During a practice consultation on collaborative medication management (CDTM), the Academy of Managed Care Pharmacy (AMCP) described the possible liability of a practicing pharmacist under such an agreement. In addition, HB 188 allows pharmacists to order a 30-day delivery of a prescription renewal for the patient if the prescription has expired and a physician is unreachable. Standard care agreements with cooperating physicians for certified nurses, certified nurse midwives and certified clinical specialized nurses must be updated before these advanced health care providers enter into consultation agreements with pharmacists. Updates to the supervisory agreements between physician assistants and supervising physicians should also be made before physician assistants enter into consultation agreements with pharmacists. With the adoption of HB 188, Ohio joins other states such as California, North Carolina, Oregon and Washington, which have recently updated their agreements on collaborative practices. Ultimately, the goal is for pharmacists to become more involved in convenient, not sprawling patient care. Ohio House Bill 188 (HB 188), passed last year, significantly expands the role of the pharmacist in Ohio by streamlining collaborative practice agreement documents and allowing physicians to enter into an agreement with multiple pharmacists to manage their patients` drug therapy. While it believes pharmacists have “more than adequate training” to provide the services authorized by the new law, the Ohio Pharmacists Association continues to create educational resources for pharmacists looking for more information about their expanded roles. Although the pharmacy has not been held liable in this case, such lawsuits may increase in frequency as pharmacists begin to play a more active role in managing drug treatment.
Hospitals, ambulatory care facilities, and all physicians who have consultation agreements with pharmacists should be aware of the physician rules adopted by the State Medical Board of Ohio, which came into effect on October 31, 2020. These new rules include updates to currently existing consultation agreements for the management of patient drug treatments and new requirements for physicians. A new medical requirement includes, for example, that the physician discuss with each patient the scope and role of the pharmacist manager under the consultation agreement and obtain the patient`s consent before the pharmacist directs the patient`s medication treatment. Previous plaintiffs have argued that pharmacists have a duty to warn patients of medications, including their risks and side effects. Other related documents that need to be reviewed and updated with respect to these new Ohio rules and laws include: Clinical Privilege and/or Job Description Forms for Pharmacists, Certified Nurse Practitioners, Certified Nurse Midwives, Clinical Nurse Specialists and Certified Physician Assistants, as well as credentials and other related policies and consent forms from Patients. Under an Ohio Collaborative Practice Agreement, pharmacists can order blood or urine tests, analyze the results, and then add, modify, or discontinue a drug without the need for a qualified physician to co-sign, provided the pharmacist`s work is performed under the Collaborative Practice Agreement. Because of the differences in pharmacy practice laws in the state, the best way for pharmacists to defend themselves against such liability claims is to take the time to familiarize themselves with them under their cooperative practice agreement to ensure that they do not exceed this authority. Pharmacists entering into cooperative practice agreements must keep abreast of clinical practice guidelines and pharmacy committee rules that apply to consultation and cooperation practice agreements.
In Ohio, Ciaccia said the state`s pharmacists` association was creating materials to prepare pharmacists for all aspects of their expanded role. “If practitioners are found to be negligent in the context of hiring CDMTs, there is a risk of legal consequences for pharmacists and physicians that are consistent with harm to a patient,” the AMCP noted. Further changes to Ohio laws will allow pharmacists to enter into consultation agreements with certified nurse practitioners, certified nurse midwives, certified clinical nurse specialists, and physician assistants as of December 16, 2020. Additional new rules will be adopted by the State Medical Board of Ohio (for physician assistants) and the Ohio Board of Nursing (for certified nurses, certified nurse midwives, and certified clinical nurse specialists) to establish the standards and requirements for these advanced health care providers to manage a patient`s medication treatment under a consultation agreement. In 48 states and the District of Columbia, the pharmacists` field of practice allows for collaborative practice agreements with prescribing physicians – although each state has its own rules and nuances on what, where and with whom pharmacists can work. The OPA`s Advancement of Practice and Innovation Committee (formerly the Pharmacotherapy Management Committee) has developed templates for Collaborative Practice Agreements (CPAs) as a benefit to OPA members in their practices. These templates include a general CPA template as well as appendices for specific diseases that can be included in a CPA. There is also a schedule for other medical conditions that pharmacists may want to include in a CPA. These documents are available in Word format so that they can be adapted to specific practice contexts. In such a case, a woman who developed Stevens-Johnson syndrome claimed that the drug manufacturer and pharmacy had carelessly failed to warn her of the rare but serious potential side effect of the urinary tract infection drug she had been prescribed and administered.
The Court of Appeal held that the manufacturer`s inclusion of the side effect in the product label protected him from any liability, the presence of the same information also protected the pharmacy from liability for a claim without warning. . 2 CPA Diabetes Anhang Model Final Draft 2.2.18. . . .